2024 Migraine Analysis and Sales Forecasts Across 68 Geographical Markets - Forecast to 2033
13 sept. 2024 06h59 HE
|
Research and Markets
Dublin, Sept. 13, 2024 (GLOBE NEWSWIRE) -- The "Migraine: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.The analyst estimates that the value of...
7MM Migraine Drug Market Forecast and Analysis to 2033: Focus on US, France, Germany, Italy, Spain, the UK, and Japan
13 sept. 2024 06h47 HE
|
Research and Markets
Dublin, Sept. 13, 2024 (GLOBE NEWSWIRE) -- The "Migraine: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering. This report provides an...
Global Migraine Competitive Landscape Market Report 2021: 90 Drugs in the Pipeline with 84% Molecules Present in Early Stage Development
21 avr. 2021 07h28 HE
|
Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Migraine - Competitive Landscape in 2021" report has been added to ResearchAndMarkets.com's offering. There are 90 drugs in the pipeline with 84%...
Migraine Pipeline Review, H2 2020: Therapeutics Development & Assessment, Drug Profiles, Dormant Projects, Discontinued Products, Development Milestones, Competitive Landscape
23 déc. 2020 08h38 HE
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Migraine - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Migraine - Pipeline Review, H2 2020,...
Global $5.1 Bn Migraine Drugs Market 2020-2024 by Mode of Administration, Treatment Class & Regions
27 oct. 2020 07h53 HE
|
Research and Markets
Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "Global Migraine Drugs Market (by Mode of Administration, Treatment Class & Regions): Insights and Forecast with Potential Impact of COVID-19...